Cervical Cancer Testing Tech Could Replace Pap Smears, Save Lives
Emerging techniques could help detect the virus leading to cervical cancer in low-income areas and developing nations.
Read MorePosted by Melanie Hamilton-Basich | Apr 5, 2021 | Cervical (HPV) |
Emerging techniques could help detect the virus leading to cervical cancer in low-income areas and developing nations.
Read MorePosted by Melanie Hamilton-Basich | Apr 5, 2021 | Mass Spectrometry, Research |
New research findings offer hope that a new test could be developed to diagnose Parkinson’s through a simple and painless skin swab.
Read MorePosted by Melanie Hamilton-Basich | Apr 2, 2021 | Covid 19 |
The high-throughput chemiluminescent immunoassay has been used to evaluate the adaptive immune response in vaccine studies.
Read MorePosted by Melanie Hamilton-Basich | Apr 1, 2021 | Covid 19 |
The hybridization capture-based approach utilized in this assay from Twist Bioscience and Biotia maximizes the number of genetic variants identified, where other sequencing methods may miss mutations in certain regions.
Read MorePosted by Melanie Hamilton-Basich | Mar 31, 2021 | Covid 19 |
FDA has created a page on its website devoted to providing information about the impact of SARS-CoV-2 viral mutations on covid-19 tests, including recommendations for clinical laboratory staff.
Read More